Akoya Biosciences Inc (AKYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -51,766 | -33,894 | -16,399 | -42,935 | -25,262 |
| Depreciation Amortization | 5,248 | 3,309 | 1,619 | 4,792 | 3,418 |
| Income taxes - deferred | 99 | 99 | 10 | -155 | -36 |
| Accounts receivable | 764 | -1,028 | -1,870 | -2,974 | -3,135 |
| Accounts payable and accrued liabilities | -1,263 | 3,937 | 2,083 | 4,361 | -1,003 |
| Other Working Capital | -2,084 | -3,325 | -5,012 | -4,561 | -12,583 |
| Other Operating Activity | 5,513 | -416 | 1,637 | 5,404 | 8,387 |
| Operating Cash Flow | $-43,489 | $-31,318 | $-17,932 | $-36,068 | $-30,214 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -29,774 | -40,774 | N/A | N/A | N/A |
| PPE Investments | -6,436 | -2,702 | -1,138 | -5,094 | -3,729 |
| Investing Cash Flow | $-36,210 | $-43,476 | $-1,138 | $-5,094 | $-3,729 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 20,000 | 10,000 | N/A | N/A | N/A |
| Debt Repayment | -458 | -316 | -126 | -322 | -250 |
| Common Stock Issued | 259 | 219 | 55 | 138,947 | 138,726 |
| Other Financing Activity | -1,345 | -1,307 | 0 | -1,590 | -1,590 |
| Financing Cash Flow | $18,456 | $8,596 | $-71 | $137,035 | $136,886 |
| Beginning Cash Position | 113,381 | 113,381 | 113,381 | 17,508 | 17,508 |
| End Cash Position | 52,138 | 47,183 | 94,240 | 113,381 | 120,451 |
| Net Cash Flow | $-61,243 | $-66,198 | $-19,141 | $95,873 | $102,943 |
| Free Cash Flow | |||||
| Operating Cash Flow | -43,489 | -31,318 | -17,932 | -36,068 | -30,214 |
| Capital Expenditure | -6,491 | -2,702 | -1,138 | -5,094 | -3,729 |
| Free Cash Flow | -49,980 | -34,020 | -19,070 | -41,162 | -33,943 |